Multiorgan ultrasound in the diagnosis of thromboembolism associated with COVID-19

General Medicine, 2025, 27(4), 42-46.

N. Kurtelova, E. Mekov, Y. Yamakova, R. Petkov

UMHAT „Sveti Ivan Rilski“ – Sofia

Аbstract. COVID-19 is a newly emerged infectious disease since late 2019, caused by the coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The subsequent global pandemic was associated with constant research aimed at improving understanding of the course of infection, the microbiological characteristics of the pathogen, and the clinical manifestations of the disease. Nowadays, increasing data and studies indicate that respiratory failure as well as coagulopathy and thromboembolic events are of paramount importance in patients with COVID-19 and they are associated with a poor prognosis. The most common thromboembolic event is pulmonary thromboembolism (PTE). This publication aims to present a clinical case with the application of multiorgan ultrasound (MOUS) for the diagnosis of PTE in this high-risk group of patients with COVID-19.

Key words: pulmonary thromboembolism, COVID-19, multiorgan ultrasound, coronavirus

Address for correspondence: Nedelina Kurtelova, MD, e-mail: nedelinakurtelova@yahoo.com